Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf5
|
ENSMUSG00000038539.8 | activating transcription factor 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_44816327_44817119 | Atf5 | 65 | 0.677000 | -0.40 | 1.5e-03 | Click! |
chr7_44817136_44817564 | Atf5 | 692 | 0.302402 | -0.32 | 1.2e-02 | Click! |
chr7_44805815_44806076 | Atf5 | 9713 | 0.072831 | 0.18 | 1.6e-01 | Click! |
chr7_44815135_44816208 | Atf5 | 13 | 0.816886 | -0.16 | 2.3e-01 | Click! |
chr7_44812951_44813102 | Atf5 | 2632 | 0.104602 | 0.12 | 3.5e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_25577192_25580600 | 0.91 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr14_66344363_66345813 | 0.88 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr2_74725879_74728683 | 0.71 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr11_84520959_84524590 | 0.70 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr16_84776020_84776193 | 0.69 |
Jam2 |
junction adhesion molecule 2 |
1720 |
0.28 |
chr2_105125289_105128976 | 0.67 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr7_79841260_79842229 | 0.64 |
Anpep |
alanyl (membrane) aminopeptidase |
608 |
0.6 |
chr13_10069245_10069396 | 0.63 |
Gm47405 |
predicted gene, 47405 |
1546 |
0.43 |
chr11_75165245_75169157 | 0.60 |
Hic1 |
hypermethylated in cancer 1 |
945 |
0.35 |
chr19_45230983_45235468 | 0.59 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr1_135821652_135822136 | 0.58 |
Lad1 |
ladinin |
3296 |
0.17 |
chr10_57784547_57786586 | 0.58 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr17_62746805_62747199 | 0.57 |
Efna5 |
ephrin A5 |
134142 |
0.05 |
chr7_101869909_101870685 | 0.55 |
Folr1 |
folate receptor 1 (adult) |
196 |
0.83 |
chr2_152080491_152081480 | 0.54 |
Scrt2 |
scratch family zinc finger 2 |
544 |
0.7 |
chr7_34660678_34660865 | 0.54 |
Kctd15 |
potassium channel tetramerisation domain containing 15 |
4039 |
0.16 |
chr5_116590520_116593206 | 0.53 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr15_72548659_72548810 | 0.53 |
Kcnk9 |
potassium channel, subfamily K, member 9 |
2394 |
0.34 |
chr5_140359964_140360399 | 0.52 |
Snx8 |
sorting nexin 8 |
201 |
0.91 |
chr12_111424483_111424634 | 0.52 |
Exoc3l4 |
exocyst complex component 3-like 4 |
2997 |
0.16 |
chr19_44755099_44757716 | 0.52 |
Pax2 |
paired box 2 |
362 |
0.83 |
chr9_21322981_21323132 | 0.51 |
Slc44a2 |
solute carrier family 44, member 2 |
2308 |
0.14 |
chr9_14609553_14609704 | 0.49 |
Amotl1 |
angiomotin-like 1 |
4958 |
0.14 |
chr7_115859202_115859391 | 0.49 |
Sox6 |
SRY (sex determining region Y)-box 6 |
556 |
0.85 |
chr11_102944952_102947140 | 0.48 |
C1ql1 |
complement component 1, q subcomponent-like 1 |
642 |
0.57 |
chr6_131352701_131354076 | 0.48 |
Styk1 |
serine/threonine/tyrosine kinase 1 |
206 |
0.92 |
chr2_118772778_118773205 | 0.48 |
Phgr1 |
proline/histidine/glycine-rich 1 |
222 |
0.88 |
chr3_129223032_129223517 | 0.47 |
Gm43697 |
predicted gene 43697 |
2254 |
0.25 |
chr8_25252967_25253374 | 0.46 |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
3399 |
0.25 |
chr18_60659778_60660175 | 0.46 |
Synpo |
synaptopodin |
166 |
0.95 |
chr4_32862939_32864770 | 0.46 |
Ankrd6 |
ankyrin repeat domain 6 |
3171 |
0.24 |
chr5_32723520_32724040 | 0.45 |
Gm2420 |
predicted gene 2420 |
3389 |
0.14 |
chr11_96202439_96204563 | 0.45 |
Hoxb13 |
homeobox B13 |
9185 |
0.1 |
chr14_64590608_64591000 | 0.45 |
Mir124a-1 |
microRNA 124a-1 |
147 |
0.74 |
chr14_54408224_54410842 | 0.45 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
73 |
0.94 |
chr4_96348255_96348420 | 0.45 |
Cyp2j11 |
cytochrome P450, family 2, subfamily j, polypeptide 11 |
325 |
0.9 |
chr4_34990546_34990697 | 0.45 |
Gm12364 |
predicted gene 12364 |
28401 |
0.15 |
chr1_92849002_92850443 | 0.45 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr3_88206822_88208169 | 0.44 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr7_131033019_131033247 | 0.44 |
Dmbt1 |
deleted in malignant brain tumors 1 |
1064 |
0.55 |
chr5_137919249_137919596 | 0.44 |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
2197 |
0.14 |
chr6_108665481_108665937 | 0.42 |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
2663 |
0.23 |
chr6_128662761_128663169 | 0.42 |
Clec2h |
C-type lectin domain family 2, member h |
574 |
0.47 |
chr10_120674522_120674673 | 0.42 |
Gm38289 |
predicted gene, 38289 |
7580 |
0.17 |
chr12_56533030_56535358 | 0.41 |
Nkx2-1 |
NK2 homeobox 1 |
912 |
0.36 |
chr10_127878471_127878622 | 0.41 |
Rdh7 |
retinol dehydrogenase 7 |
9784 |
0.09 |
chr2_74686971_74688120 | 0.40 |
Gm28309 |
predicted gene 28309 |
4099 |
0.06 |
chr10_42941048_42942047 | 0.40 |
Scml4 |
Scm polycomb group protein like 4 |
1666 |
0.38 |
chr9_65354734_65354885 | 0.40 |
Ubap1l |
ubiquitin-associated protein 1-like |
6232 |
0.09 |
chr19_55123910_55124428 | 0.40 |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
3034 |
0.26 |
chr16_24102999_24103416 | 0.40 |
Gm31583 |
predicted gene, 31583 |
13118 |
0.17 |
chr16_34571070_34571404 | 0.40 |
Kalrn |
kalirin, RhoGEF kinase |
2295 |
0.41 |
chr19_34691351_34691502 | 0.39 |
Slc16a12 |
solute carrier family 16 (monocarboxylic acid transporters), member 12 |
121 |
0.95 |
chr10_4080039_4080600 | 0.39 |
Gm25515 |
predicted gene, 25515 |
23994 |
0.18 |
chr7_62045951_62046251 | 0.39 |
Mir344f |
microRNA Mir344f |
147 |
0.94 |
chr13_54191853_54192989 | 0.39 |
Hrh2 |
histamine receptor H2 |
292 |
0.9 |
chr18_25752531_25753655 | 0.38 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr7_44586495_44587690 | 0.38 |
Napsa |
napsin A aspartic peptidase |
2277 |
0.11 |
chr6_71496822_71497162 | 0.38 |
Rnf103 |
ring finger protein 103 |
2989 |
0.16 |
chr15_103009345_103011570 | 0.38 |
Hoxc6 |
homeobox C6 |
884 |
0.35 |
chr11_49981842_49982032 | 0.38 |
Rasgef1c |
RasGEF domain family, member 1C |
18152 |
0.17 |
chr15_102965066_102967702 | 0.38 |
Hoxc10 |
homeobox C10 |
412 |
0.6 |
chr11_96272013_96272961 | 0.38 |
Hoxb9 |
homeobox B9 |
964 |
0.29 |
chr1_74856793_74857207 | 0.37 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
2066 |
0.19 |
chr15_103011882_103012844 | 0.37 |
Hoxc5 |
homeobox C5 |
1452 |
0.19 |
chr7_25176596_25177413 | 0.37 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
2722 |
0.15 |
chr17_31834583_31834734 | 0.37 |
Sik1 |
salt inducible kinase 1 |
16917 |
0.15 |
chr17_23600678_23600829 | 0.37 |
Zscan10 |
zinc finger and SCAN domain containing 10 |
103 |
0.89 |
chr14_60642924_60643184 | 0.37 |
Spata13 |
spermatogenesis associated 13 |
8299 |
0.24 |
chr2_37765684_37765835 | 0.36 |
Crb2 |
crumbs family member 2 |
10490 |
0.2 |
chr7_75498780_75498931 | 0.36 |
Gm44695 |
predicted gene 44695 |
13994 |
0.17 |
chr1_5018491_5020565 | 0.36 |
Rgs20 |
regulator of G-protein signaling 20 |
11 |
0.98 |
chr3_25807553_25807810 | 0.36 |
Gm6197 |
predicted gene 6197 |
76438 |
0.12 |
chr13_83544795_83544946 | 0.36 |
Mef2c |
myocyte enhancer factor 2C |
14732 |
0.27 |
chr16_91219818_91221532 | 0.35 |
Gm49614 |
predicted gene, 49614 |
2251 |
0.2 |
chr11_89298118_89300658 | 0.35 |
Nog |
noggin |
2944 |
0.27 |
chr8_15031239_15031390 | 0.35 |
Kbtbd11 |
kelch repeat and BTB (POZ) domain containing 11 |
1076 |
0.32 |
chr9_96696155_96696446 | 0.35 |
A930006L05Rik |
RIKEN cDNA A930006L05 gene |
9528 |
0.17 |
chr2_147189265_147191223 | 0.35 |
6430503K07Rik |
RIKEN cDNA 6430503K07 gene |
2820 |
0.2 |
chr17_47276069_47276254 | 0.35 |
Gm26216 |
predicted gene, 26216 |
14795 |
0.17 |
chr11_105731735_105732401 | 0.35 |
Tanc2 |
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 |
18528 |
0.2 |
chr8_12400578_12402091 | 0.35 |
Gm25239 |
predicted gene, 25239 |
4931 |
0.15 |
chr13_23914465_23914923 | 0.35 |
Slc17a4 |
solute carrier family 17 (sodium phosphate), member 4 |
274 |
0.81 |
chr10_96687019_96687214 | 0.34 |
Gm48507 |
predicted gene, 48507 |
24691 |
0.18 |
chr5_75148315_75152589 | 0.34 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr4_41502058_41503518 | 0.34 |
Myorg |
myogenesis regulating glycosidase (putative) |
120 |
0.93 |
chr6_115591641_115592523 | 0.34 |
Mkrn2os |
makorin, ring finger protein 2, opposite strand |
467 |
0.71 |
chr1_135917032_135917598 | 0.34 |
Pkp1 |
plakophilin 1 |
1805 |
0.28 |
chr7_24544074_24544225 | 0.34 |
Pinlyp |
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
1969 |
0.14 |
chr2_103303542_103303697 | 0.34 |
Ehf |
ets homologous factor |
341 |
0.88 |
chr12_5372086_5372237 | 0.33 |
Klhl29 |
kelch-like 29 |
3521 |
0.26 |
chr2_163548522_163549154 | 0.33 |
Hnf4a |
hepatic nuclear factor 4, alpha |
1245 |
0.35 |
chr4_32987739_32987890 | 0.33 |
Rragd |
Ras-related GTP binding D |
4360 |
0.15 |
chr14_56620318_56620492 | 0.33 |
Gm16573 |
predicted gene 16573 |
92 |
0.96 |
chr11_45858851_45859002 | 0.33 |
Clint1 |
clathrin interactor 1 |
6962 |
0.16 |
chr1_173912576_173913112 | 0.33 |
Ifi211 |
interferon activated gene 211 |
202 |
0.91 |
chr16_17235946_17236097 | 0.33 |
Hic2 |
hypermethylated in cancer 2 |
2357 |
0.15 |
chr7_43635657_43635808 | 0.33 |
Ceacam18 |
carcinoembryonic antigen-related cell adhesion molecule 18 |
1025 |
0.32 |
chr2_150859020_150859321 | 0.33 |
Abhd12 |
abhydrolase domain containing 12 |
7680 |
0.14 |
chr11_42423566_42423717 | 0.33 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
2291 |
0.44 |
chr18_47760278_47760640 | 0.33 |
Gm41720 |
predicted gene, 41720 |
27351 |
0.15 |
chr13_60172478_60172987 | 0.33 |
Gm48488 |
predicted gene, 48488 |
3950 |
0.19 |
chr15_61690376_61690923 | 0.32 |
D030024E09Rik |
RIKEN cDNA D030024E09 gene |
54535 |
0.16 |
chr12_4592745_4593903 | 0.32 |
Itsn2 |
intersectin 2 |
262 |
0.51 |
chr7_43409103_43409254 | 0.32 |
Siglecg |
sialic acid binding Ig-like lectin G |
705 |
0.41 |
chr1_43160684_43161180 | 0.32 |
Fhl2 |
four and a half LIM domains 2 |
3029 |
0.23 |
chr19_43596014_43596165 | 0.32 |
Gm20467 |
predicted gene 20467 |
14536 |
0.1 |
chr2_103300857_103301025 | 0.32 |
Ehf |
ets homologous factor |
1376 |
0.43 |
chr4_41496772_41496923 | 0.32 |
Myorg |
myogenesis regulating glycosidase (putative) |
5821 |
0.11 |
chr17_34264490_34265484 | 0.32 |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
1656 |
0.18 |
chr12_81166293_81166444 | 0.32 |
Mir3067 |
microRNA 3067 |
217 |
0.95 |
chr12_49387532_49388566 | 0.32 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr9_113968662_113968987 | 0.32 |
Ubp1 |
upstream binding protein 1 |
401 |
0.82 |
chr10_31600190_31600341 | 0.32 |
Rnf217 |
ring finger protein 217 |
8919 |
0.18 |
chr18_43493989_43494183 | 0.32 |
Eif3j2 |
eukaryotic translation initiation factor 3, subunit J2 |
16290 |
0.14 |
chr14_32515447_32515598 | 0.32 |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
1992 |
0.3 |
chr8_71670829_71671681 | 0.32 |
Unc13a |
unc-13 homolog A |
481 |
0.62 |
chr1_93100315_93101980 | 0.32 |
Kif1a |
kinesin family member 1A |
675 |
0.62 |
chr17_91092075_91093120 | 0.32 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr14_68121009_68121517 | 0.32 |
Nefm |
neurofilament, medium polypeptide |
3583 |
0.21 |
chr8_121088119_121090419 | 0.31 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr19_54045999_54046443 | 0.31 |
Adra2a |
adrenergic receptor, alpha 2a |
961 |
0.54 |
chr3_129216664_129219042 | 0.31 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr3_9704893_9705172 | 0.31 |
Pag1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
30 |
0.98 |
chr18_43058416_43059778 | 0.31 |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
374 |
0.86 |
chr12_84624553_84624704 | 0.31 |
Abcd4 |
ATP-binding cassette, sub-family D (ALD), member 4 |
7215 |
0.16 |
chr9_102783167_102783318 | 0.31 |
Gm47416 |
predicted gene, 47416 |
11747 |
0.13 |
chr5_150906704_150906899 | 0.31 |
Gm43298 |
predicted gene 43298 |
24159 |
0.17 |
chr1_128355344_128355660 | 0.31 |
Mcm6 |
minichromosome maintenance complex component 6 |
4145 |
0.2 |
chr15_98761306_98761457 | 0.31 |
Arf3 |
ADP-ribosylation factor 3 |
1611 |
0.21 |
chr12_72939449_72940864 | 0.31 |
4930447C04Rik |
RIKEN cDNA 4930447C04 gene |
73 |
0.75 |
chrX_161109774_161109925 | 0.31 |
Scml2 |
Scm polycomb group protein like 2 |
7344 |
0.3 |
chr2_164835534_164835852 | 0.30 |
Ctsa |
cathepsin A |
1220 |
0.22 |
chr6_28319495_28319646 | 0.30 |
Gm5303 |
predicted gene 5303 |
43595 |
0.11 |
chr15_98867250_98867861 | 0.30 |
Kmt2d |
lysine (K)-specific methyltransferase 2D |
3628 |
0.09 |
chr9_78585809_78585960 | 0.30 |
Slc17a5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
2131 |
0.26 |
chr1_84619208_84619870 | 0.30 |
Dner |
delta/notch-like EGF repeat containing |
4302 |
0.26 |
chr1_152526428_152526750 | 0.30 |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
26455 |
0.21 |
chr1_42700192_42700666 | 0.30 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
4661 |
0.15 |
chr1_177444257_177446079 | 0.30 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr14_79202853_79203004 | 0.30 |
Gm4632 |
predicted gene 4632 |
3738 |
0.19 |
chr8_100790829_100791145 | 0.30 |
Gm39232 |
predicted gene, 39232 |
64632 |
0.15 |
chr10_80255554_80255705 | 0.30 |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
2314 |
0.12 |
chr6_28132179_28132696 | 0.30 |
Grm8 |
glutamate receptor, metabotropic 8 |
692 |
0.74 |
chr3_27371157_27372632 | 0.30 |
Ghsr |
growth hormone secretagogue receptor |
543 |
0.81 |
chr2_49811588_49812114 | 0.29 |
Gm13480 |
predicted gene 13480 |
1097 |
0.57 |
chr6_117407013_117407247 | 0.29 |
Gm4640 |
predicted gene 4640 |
16487 |
0.22 |
chr3_89901236_89901387 | 0.29 |
Gm42809 |
predicted gene 42809 |
11605 |
0.11 |
chr5_135851944_135852754 | 0.29 |
Srrm3 |
serine/arginine repetitive matrix 3 |
2065 |
0.18 |
chr19_43606378_43607779 | 0.29 |
Gm20467 |
predicted gene 20467 |
3547 |
0.14 |
chr19_45050458_45050609 | 0.29 |
Sfxn3 |
sideroflexin 3 |
2655 |
0.15 |
chr4_130802234_130802571 | 0.29 |
Sdc3 |
syndecan 3 |
9536 |
0.11 |
chr6_92532028_92532621 | 0.29 |
Prickle2 |
prickle planar cell polarity protein 2 |
2537 |
0.35 |
chr6_6101593_6101809 | 0.29 |
Slc25a13 |
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 |
6498 |
0.29 |
chr7_19002299_19002450 | 0.29 |
Mypopos |
Myb-related transcription factor, partner of profilin, opposite strand |
1152 |
0.22 |
chr2_27686722_27686873 | 0.29 |
Rxra |
retinoid X receptor alpha |
9535 |
0.26 |
chr15_102972226_102973378 | 0.29 |
Mir196a-2 |
microRNA 196a-2 |
548 |
0.53 |
chrX_134746783_134746934 | 0.28 |
Gm10344 |
predicted gene 10344 |
55 |
0.95 |
chr6_52317834_52318208 | 0.28 |
Evx1os |
even skipped homeotic gene 1, opposite strand |
3189 |
0.12 |
chr9_110732320_110733579 | 0.28 |
Myl3 |
myosin, light polypeptide 3 |
8912 |
0.11 |
chr15_25408835_25409622 | 0.28 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
4470 |
0.17 |
chr2_77312672_77312965 | 0.28 |
Gm13943 |
predicted gene 13943 |
1933 |
0.29 |
chr13_63554202_63556305 | 0.28 |
Ptch1 |
patched 1 |
8562 |
0.14 |
chr13_73700417_73700616 | 0.28 |
Slc6a19 |
solute carrier family 6 (neurotransmitter transporter), member 19 |
165 |
0.86 |
chr10_127103666_127103988 | 0.28 |
Os9 |
amplified in osteosarcoma |
17288 |
0.07 |
chr10_99353403_99354040 | 0.28 |
B530045E10Rik |
RIKEN cDNA B530045E10 gene |
49069 |
0.1 |
chr13_48593010_48593372 | 0.28 |
Ptpdc1 |
protein tyrosine phosphatase domain containing 1 |
169 |
0.66 |
chr1_127854632_127855097 | 0.28 |
Map3k19 |
mitogen-activated protein kinase kinase kinase 19 |
167 |
0.95 |
chrX_11994206_11994438 | 0.27 |
Gm14512 |
predicted gene 14512 |
9854 |
0.25 |
chr19_36911587_36911738 | 0.27 |
Fgfbp3 |
fibroblast growth factor binding protein 3 |
7937 |
0.19 |
chr9_91382435_91383240 | 0.27 |
Zic4 |
zinc finger protein of the cerebellum 4 |
427 |
0.7 |
chr5_121925225_121926346 | 0.27 |
Cux2 |
cut-like homeobox 2 |
864 |
0.58 |
chr13_56258424_56259826 | 0.27 |
Neurog1 |
neurogenin 1 |
6962 |
0.15 |
chr4_115495812_115495963 | 0.27 |
Cyp4a14 |
cytochrome P450, family 4, subfamily a, polypeptide 14 |
253 |
0.87 |
chr1_72534104_72534255 | 0.27 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
2751 |
0.3 |
chrX_133908388_133909247 | 0.27 |
Srpx2 |
sushi-repeat-containing protein, X-linked 2 |
369 |
0.84 |
chrX_71962278_71963567 | 0.27 |
Prrg3 |
proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) |
60 |
0.97 |
chr19_7421074_7423945 | 0.27 |
Mir6991 |
microRNA 6991 |
64 |
0.94 |
chrX_168795135_168796925 | 0.27 |
Arhgap6 |
Rho GTPase activating protein 6 |
931 |
0.65 |
chr17_27000055_27000509 | 0.27 |
Ggnbp1 |
gametogenetin binding protein 1 |
17705 |
0.07 |
chr14_39469812_39470401 | 0.27 |
Nrg3 |
neuregulin 3 |
2560 |
0.44 |
chr9_75683375_75684591 | 0.27 |
Scg3 |
secretogranin III |
8 |
0.97 |
chr1_113765570_113765721 | 0.27 |
Gm24937 |
predicted gene, 24937 |
47598 |
0.19 |
chr13_47452309_47452762 | 0.27 |
Gm35733 |
predicted gene, 35733 |
91149 |
0.08 |
chr11_65257671_65257990 | 0.26 |
Myocd |
myocardin |
12024 |
0.2 |
chr17_48457449_48458038 | 0.26 |
Unc5cl |
unc-5 family C-terminal like |
2842 |
0.18 |
chr15_40978399_40979507 | 0.26 |
Gm49524 |
predicted gene, 49524 |
19007 |
0.21 |
chr3_90669217_90670598 | 0.26 |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
596 |
0.55 |
chr3_129803440_129803831 | 0.26 |
Lrit3 |
leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 |
395 |
0.78 |
chr8_109248831_109249717 | 0.26 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
592 |
0.83 |
chr13_15548557_15548708 | 0.26 |
Gli3 |
GLI-Kruppel family member GLI3 |
84652 |
0.08 |
chr14_118227252_118227749 | 0.26 |
Gm4675 |
predicted gene 4675 |
8732 |
0.13 |
chr19_44698622_44699172 | 0.26 |
Gm26644 |
predicted gene, 26644 |
3437 |
0.21 |
chr5_112213199_112213350 | 0.26 |
Gm26953 |
predicted gene, 26953 |
2187 |
0.21 |
chr5_93265533_93265713 | 0.26 |
Ccng2 |
cyclin G2 |
1634 |
0.36 |
chr8_78432202_78432747 | 0.26 |
Pou4f2 |
POU domain, class 4, transcription factor 2 |
4171 |
0.24 |
chr14_122453119_122454531 | 0.26 |
Gm5089 |
predicted gene 5089 |
2710 |
0.17 |
chr18_74443561_74444791 | 0.26 |
Myo5b |
myosin VB |
1569 |
0.38 |
chr3_63297848_63298469 | 0.26 |
Mme |
membrane metallo endopeptidase |
1106 |
0.63 |
chr9_49340496_49341455 | 0.26 |
Drd2 |
dopamine receptor D2 |
348 |
0.91 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.2 | 0.7 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
0.2 | 0.4 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.5 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
0.1 | 0.4 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.1 | 0.6 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.1 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.2 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.3 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.1 | 0.1 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.1 | 0.1 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.2 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.1 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.3 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.1 | 0.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.1 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.0 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.1 | GO:1904746 | negative regulation of apoptotic process involved in morphogenesis(GO:1902338) negative regulation of apoptotic process involved in development(GO:1904746) |
0.0 | 0.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.0 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.0 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.0 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.0 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.7 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.0 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.0 | 0.1 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
0.0 | 0.1 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.2 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.0 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.0 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.0 | 0.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.0 | 0.4 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.0 | 0.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.2 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.0 | 0.1 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.1 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0014028 | notochord formation(GO:0014028) |
0.0 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.0 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.0 | 0.1 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.0 | 0.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.4 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.2 | GO:0086015 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.0 | 0.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.0 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.0 | 0.1 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.2 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.0 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.0 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.1 | GO:0015810 | aspartate transport(GO:0015810) |
0.0 | 0.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.0 | 0.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.0 | 0.1 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.0 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
0.0 | 0.1 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.0 | 0.0 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 0.1 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.1 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.0 | 0.1 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.0 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.0 | 0.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.0 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.0 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.0 | 0.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 0.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.0 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.0 | 0.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.0 | 0.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.0 | 0.0 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.0 | 0.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.1 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.0 | 0.0 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.1 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.1 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.0 | 0.1 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.0 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.0 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.0 | 0.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.0 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.0 | 0.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.0 | 0.1 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.1 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.0 | 0.0 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.0 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.0 | 0.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.2 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 1.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.0 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.0 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.0 | 0.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.2 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.2 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.0 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.0 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.0 | 0.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.0 | 0.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.1 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.0 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.0 | 0.0 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.0 | 0.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.0 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.2 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.0 | 0.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.0 | 0.6 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.2 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.1 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.0 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.0 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.2 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 0.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.2 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.0 | 0.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 0.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.1 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.0 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.0 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.0 | 0.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.0 | GO:0034806 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.0 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 2.8 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.0 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 0.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.2 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |